跳至主要内容
临床试验/EUCTR2007-005045-38-IT
EUCTR2007-005045-38-IT进行中(未招募)不适用

Pharmacokinetic and colimicine (ColistinaR) concentrations in broncho alveolar lavage in patients affected by pulmonary infections caused by Gram - bacteria. - ND

OSPEDALE POLICLINICO S. MATTEO0 个研究点开始时间: 2007年11月22日最近更新:
相关药物

试验速览

阶段
不适用
状态
进行中(未招募)
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • age > 18 years, patient with pulmonary infection, needing respiratory assistance, secretion containing Gram -
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range

排除标准

  • age < 18 years, patient with known sensibility to colimicine, pregnant woman

研究者

发起方
OSPEDALE POLICLINICO S. MATTEO

相似试验

进行中(未招募)
1 期
Pharmacokinetic/pharmacodynamic aspects of colistin intravenous administration in critically ill patients suffering from hospital infections caused by multi-antibiotic-resistant germs and receiving continuous renal replacement therapy.Critically ill patients suffering from hospital infections caused by multi-antibiotic-resistant germs and receiving continuous renal replacement therapy.MedDRA version: 20.0Level: PTClassification code 10053840Term: Bacterial sepsisSystem Organ Class: 10021881 - Infections and infestations
EUCTR2021-001019-95-ITFONDAZIONE POLICLINICO UNIVERSITARIO AGOSTINO GEMELLI IRCCS UNIVERSITA' CATTOLICA DEL SACRO CUORE20
进行中(未招募)
不适用
Pharmacokinetics of colistimethate and colistine after a 60 minutes intravenous infusion of colistimethate 1 million UI (80 mg) in 12 healthy volunteers
EUCTR2007-003092-39-FRCHU DE POITIERS
尚未招募
Unknown
Clinical efficacy and pharmacokinetics of colistimethate sodium in pediatric patients.
CTRI/2023/04/051382AIIMS RAIPUR
已完成
4 期
A clinical trial to determine pharmacokinetics of Colistin given as injection, in subjects with hospital acquired infections caused by gram negative bacilli.
CTRI/2009/091/000252Cipla Ltd12
已完成
不适用
An exploratory study of administration of colistin for multidrug-resistant Pseudomonas aeruginosa infections in patients with hematological disease.multidrug-resistant Pseudomonas aeruginosa infections in patients with hematological disease.
JPRN-UMIN000002122niversity of Tokyo Hospital Department of Hamatology and Oncology5